AI Article Synopsis

  • A study examined the effectiveness of proton-pump inhibitors (PPIs) and vonoprazan in preventing delayed bleeding after esophageal endoscopic submucosal dissection (ESD), as their efficacy in this context was previously unclear.
  • Researchers analyzed data from over 54,000 patients who underwent esophageal ESD between 2012 and 2020, comparing bleeding rates in those prescribed PPIs or vonoprazan to those with no acid suppression.
  • The results indicated no significant difference in delayed bleeding rates between the two groups, suggesting that prescribing PPIs or vonoprazan for this purpose may not be recommended.

Article Abstract

Although proton-pump inhibitor (PPI) administration was reported to be effective in preventing delayed bleeding after gastric endoscopic submucosal dissection (ESD), its effectiveness in esophageal ESD is still unknown. We assessed whether PPI or vonoprazan administration was effective in preventing posterior hemorrhage after esophageal ESD. This retrospective cohort study used the Japanese Diagnosis Procedure Combination (DPC) database, and patients who underwent esophageal ESD between January 2012 and December 2020 were enrolled. The participants were divided into two groups: patients who were prescribed PPI or vonoprazan (PPI or vonoprazan group) and those who were not prescribed PPI (no acid suppression). Propensity score matching analysis was performed, and the delayed bleeding rate was compared between the groups. We analyzed 54,345 patients, of whom 8237 (15.16%) were in the no acid suppression group and 46,108 (84.84%) in the PPI or vonoprazan group (PPI: 34,380 and vonoprazan: 11,728). Delayed bleeding occurred in 1126 patients (2.07%). A total of 8237 pairs were created after matching. Delayed bleeding was not significantly different between the no acid suppression group and PPI or vonoprazan group, respectively (odds ratio: 1.20, 95% confidential interval: 0.93-1.54, P = 0.227). A sub-analysis according to the dose of PPI or vonoprazan, tumor location, and prescription of antithrombotic or anticoagulant medications was performed, but no significant effects of PPI or vonoprazan administration were found. PPI or vonoprazan did not prevent delayed bleeding; thus, the prescription of PPI and vonoprazan after esophageal ESD may not be recommended for the prevention of delayed bleeding.

Download full-text PDF

Source
http://dx.doi.org/10.1093/dote/doad060DOI Listing

Publication Analysis

Top Keywords

ppi vonoprazan
36
delayed bleeding
24
esophageal esd
16
effective preventing
12
ppi
12
vonoprazan group
12
acid suppression
12
vonoprazan
10
proton-pump inhibitor
8
endoscopic submucosal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!